Mechanisms of Behavioral Activation (BA)
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT05548244
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 15 Years - 17 Years
- Healthy Volunteers
- Accepted
Interventions
- Behavioral Activation Therapy — BEHAVIORALParticipants will be seen for a maximum of 16 sessions of therapy focused on increasing rewarding behaviors (16 individual therapy sessions of 1-hour, 2 of which include the BSIS component) over 16 weeks. BA intervention includes monthly booster sessions offered throughout 6-month follow up. If needed, two extra sessions will be allowed during treatment.
- Baseline assessment procedures — BEHAVIORALCompletion of the K-SADS and CDRS-R to assess MDD, and the Wechsler Abbreviated Scale of Intelligence - 2nd Edition to assess IQ.
Study Details
The investigators will be comparing brain (neural) activation of depressed adolescent patients before, during and after a course of Behavioral Activation (BA) therapy using functional magnetic resonance imaging (fMRI). In particular, the project seeks to determine whether BA targets different neural mechanisms for behavioral avoidance associated with low motivation as compared to threat avoidance. A group of healthy controls will also be scanned as a comparator group for behavioral and imaging measures.
Key Dates
- Start date
- Jan 30, 2023
- Status verified
- May 2026
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 136 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: MDD patientsParticipants will be seen for a maximum of 16 sessions over 16 weeks. Two extra sessions will be allowed during treatment.
Primary Outcome Measure
Change in Diagnostic Interview Status (CDRS-R) total score from baseline [ Time Frame: Baseline, week 16 post intervention ]
Central Contacts
- Wade E Craighead, PhD4047273287
- Michael Treadway, PhD
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Child and Adolescent Mood Program (CAMP) | Atlanta | Georgia | 30329 | Wade E Craighead, PhD |
| Emory University | Atlanta | Georgia | 30322 | Wade E Craighead, PhD |
| Facility for Education and Research in Neuroscience (FERN) | Atlanta | Georgia | 30322 | Michael Treadway, PhD |
Find similar trials in Atlanta, GA
By condition
By specialty
Related Studies
- Suicidal Behavior in Patients Diagnosed With Bipolar DisorderRecruiting · Emory University · Atlanta, Georgia
- Brain Stimulation and Decision-makingRecruiting · Emory University · Atlanta, Georgia
- A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.PHASE3 · Recruiting · AbbVie · Bentonville, Arkansas
- Inflammation and Depression in People With HIVPHASE2 · Recruiting · Emory University · Atlanta, Georgia